10-14/12/2018 - Εκπαιδευτικό Πρόγραμμα | GMP-compliant CAR T Cell Manufacturing (Γερμανία)

Based on the high interest and the huge success of 2017’s training event, CARAT will offer a second training event in 2018 to transfer knowledge on GMP-compliant CAR T cell manufacturing to an even higher number of scientists. The course is limited to a maximum of five attendees.

It will take place at Miltenyi Biotec´s headquarter in Germany in December 2018 and focuses on practical, regulatory and scientific issues. Applicants from EU Member States and Associated Countries are encouraged to participate.

Target Group

Scientists with a profound background in cellular and gene therapy who intend to initiate clinical applications in the near future.

Date and Location

The training event will take place on December 10-14, 2018 in Bergisch Gladbach, Germany.

The objectives of this training event are:

To introduce the cell separation technology on the CliniMACS Prodigy Platform
To deliver the versatility and limitations of the current T cell transduction (TCT) process
To enable the trainee to perform independently automated manufacture of cellular products: all process phases, such as selection, activation, transduction, and expansion are explained/demonstrated with special regard to user interaction and process versatility
To enable the trainee to handle common situations of the TCT process like GMP logistics, monitoring, basic troubleshooting
To deepen practical expertise via extensive hands-on exercises
To discuss regulatory requirements like trial design, approval or IMPD (Investigational Medicinal Product Dossier)

The fellowship will include:

Training materials (presentations and exercises), usage of equipment and consumables
Catering during the course
One hosted dinner
Hotel accommodation (five nights)
Transportation between hotel and MACS® Academy
Travel expenses up to 500€/pp
Certificate of completion

All applications will be reviewed based on the following criteria:

Scientific background of the applicant (reference to cell therapies/planned clinical applications of cell/gene therapy in the near future)
Gender balance and regional aspects

Αναλυτικές πληροφορίες - Δηλώσεις συμμετοχής: carat-horizon2020.eu